Enhanced Anti-tumor Effect of Trastuzumab in Combination with Cisplatin
نویسندگان
چکیده
منابع مشابه
Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells.
Women with triple-negative breast cancer (TNBC) have a worse prognosis compared with other breast cancer subtypes. Hormonal or Herceptin-based therapies were found to be ineffective because of the loss of target receptors, such as ER, PR, and HER-2 amplification. Conventional chemo- and/ or radiation therapy also seems to have limited efficacy in TNBC patients. We studied the effects of cisplat...
متن کاملCombination antitumor effect of GM-CSF tumor vaccine with cisplatin for mice with subcutaneous transplanted tumor
Background: Non-small-cell lung cancer has a relatively high remission rate for initial chemotherapy. However, it is very liable to appear adoptive resistance. Irradiated tumor cells modified with GM-CSF are very effective in triggering immune responses. Therefore, combined therapy of tumor cell vaccine expressing GM-CSF with chemotherapy for NSCLC should be focused on. Objectives: To study the...
متن کاملAnti-cancer effect of Scutellaria baicalensis in combination with cisplatin in human ovarian cancer cell
BACKGROUND Ovarian cancer is one of the major causes of death among females in worldwide. Cisplatin is a primary anti-cancer drug against ovarian cancer, but the recurrent tumors after treatment frequently show acquired chemoresistance. Extract of Scutellaria baicalensis (SbE) has been reported to have functional compounds including baicalin, which has anti-cancer effects. However, the anti-can...
متن کاملSynergistic Anti-Tumor Effect of Cisplatin When Combined with an Anti-Src Kinase Integrin-Based Peptide
Background: It is known that active Src kinase promotes survival of ovarian cancer cell lines and inhibition of c-Src has been shown to restore sensitivity of drug-resistant human ovarian cancer cells to cisplatin. In this study we examined the effects of a 10 mer peptide on proliferation of human colon and ovarian cancer cells when used alone and in combination with cisplatin. Materials and Me...
متن کاملDiscovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor
Tumor cells upregulate many cell signaling pathways, with AKT being one of the key kinases to be activated in a variety of malignancies. GSK2110183 and GSK2141795 are orally bioavailable, potent inhibitors of the AKT kinases that have progressed to human clinical studies. Both compounds are selective, ATP-competitive inhibitors of AKT 1, 2 and 3. Cells treated with either compound show decrease...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Journal of Cancer Research
سال: 2002
ISSN: 0910-5050
DOI: 10.1111/j.1349-7006.2002.tb01293.x